» Articles » PMID: 23652249

A Technique to Use CT Images for in Vivo Detection and Quantification of the Spatial Distribution of Radiation-induced Esophagitis

Overview
Date 2013 May 9
PMID 23652249
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of the study was to examine whether CT imaging can be used to quantify radiation-induced injury to the esophagus. Weekly CT images for 14 patients receiving proton therapy for thoracic tumors were retrospectively reviewed. The images were registered with the original treatment planning CT image using deformable registration techniques, and the esophageal contours from the treatment plan were automatically mapped to the weekly images. The relative change in the size of the esophagus was calculated for each CT slice as the ratio of the cross-sectional area of the esophagus (minus air) in the weekly CT image to the same area in the planning CT image. The maximum relative change in cross sectional area for each CT image was calculated and examined for correlation with the clinical toxicity score for all the patients. The average maximum relative expansion of the esophagus at the end of treatment was 1.41 ± 0.26, 1.68 ± 0.36, and 2.10 ± 0.18 for patients with grade 0, 2, and 3 esophagitis, respectively. An unpaired t-test, with the level of significance corrected with a Bonferroni correction, showed that the difference between grade 3 and 0 was significant, but the differences between grade 0 and 2, and 2 and 3 were not. The timing of changes in esophageal expansion closely matched that of clinically noted changes in patient symptoms. Expansion of the esophagus on CT images has potential as an objective measure of toxicity. The ability to quantify objectively the spatial distribution of radiation-induced injury will be a useful tool in understanding the impact of partial esophageal sparing on the probability of esophagitis.

Citing Articles

Artificial intelligence-based automated segmentation and radiotherapy dose mapping for thoracic normal tissues.

Jiang J, Choi C, Deasy J, Rimner A, Thor M, Veeraraghavan H Phys Imaging Radiat Oncol. 2024; 29:100542.

PMID: 38369989 PMC: 10869275. DOI: 10.1016/j.phro.2024.100542.


Early Prediction of Acute Esophagitis for Adaptive Radiation Therapy.

Alam S, Zhang P, Zhang S, Chen I, Rimner A, Tyagi N Int J Radiat Oncol Biol Phys. 2021; 110(3):883-892.

PMID: 33453309 PMC: 8180486. DOI: 10.1016/j.ijrobp.2021.01.007.


Quantification of accumulated dose and associated anatomical changes of esophagus using weekly Magnetic Resonance Imaging acquired during radiotherapy of locally advanced lung cancer.

Alam S, Thor M, Rimner A, Tyagi N, Zhang S, Kuo L Phys Imaging Radiat Oncol. 2020; 13:36-43.

PMID: 32411833 PMC: 7224352. DOI: 10.1016/j.phro.2020.03.002.


Evaluation of acute esophageal radiation-induced damage using magnetic resonance imaging: a feasibility study in mice.

Jelvehgaran P, Steinberg J, Khmelinskii A, Borst G, Song J, de Wit N Radiat Oncol. 2019; 14(1):188.

PMID: 31666092 PMC: 6822441. DOI: 10.1186/s13014-019-1396-8.


Optical coherence tomography to detect acute esophageal radiation-induced damage in mice: A validation study.

Jelvehgaran P, de Bruin D, Khmelinskii A, Borst G, Steinberg J, Song J J Biophotonics. 2019; 12(9):e201800440.

PMID: 31058437 PMC: 7065648. DOI: 10.1002/jbio.201800440.


References
1.
Belderbos J, Heemsbergen W, Hoogeman M, Pengel K, Rossi M, Lebesque J . Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy. Radiother Oncol. 2005; 75(2):157-64. DOI: 10.1016/j.radonc.2005.03.021. View

2.
Furuse K, Fukuoka M, Kawahara M, Nishikawa H, Takada Y, Kudoh S . Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol. 1999; 17(9):2692-9. DOI: 10.1200/JCO.1999.17.9.2692. View

3.
Wei X, Liu H, Tucker S, Liao Z, Hu C, Mohan R . Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2006; 66(1):100-7. DOI: 10.1016/j.ijrobp.2006.04.022. View

4.
Kang Y, Zhang X, Chang J, Wang H, Wei X, Liao Z . 4D Proton treatment planning strategy for mobile lung tumors. Int J Radiat Oncol Biol Phys. 2007; 67(3):906-14. DOI: 10.1016/j.ijrobp.2006.10.045. View

5.
Berkovich G, Levine M, Miller Jr W . CT findings in patients with esophagitis. AJR Am J Roentgenol. 2000; 175(5):1431-4. DOI: 10.2214/ajr.175.5.1751431. View